Custom laboratory information management systems for chemical, pharmaceutical, food, and materials manufacturers — sample tracking, test scheduling, instrument integration, COA generation, specification management, out-of-spec workflows, and stability studies. FreedomDev has 20+ years building QC lab systems in Zeeland, Michigan, for manufacturers where a failed batch release, a missed stability pull, or a lost chain-of-custody record is not an IT inconvenience — it is a regulatory finding, a customer rejection, or a product recall.
Manufacturing QC labs that still run on spreadsheets, paper logbooks, and standalone instrument software are carrying three categories of cost that compound with every batch they release: labor waste, data integrity risk, and regulatory exposure. The labor cost alone is staggering. A typical mid-size chemical or pharmaceutical manufacturer processes 200 to 500 samples per week across incoming raw materials, in-process checks, finished product release testing, and stability pulls. Each sample generates 3 to 15 individual test results depending on the product specification. Without a LIMS, every one of those results gets recorded by hand in a paper logbook or typed into an Excel spreadsheet, then manually compared against the product specification, then transcribed onto a Certificate of Analysis, then filed in a binder or a shared drive folder. A QC technician performing this workflow spends 30 to 45 minutes per sample on documentation alone — time that produces zero analytical value. At 300 samples per week, that is 150 to 225 hours of manual documentation labor. That is 4 to 6 full-time employees doing nothing but writing down numbers, checking numbers against spec limits, and copying numbers onto COAs. At a loaded cost of $55,000 to $70,000 per QC technician, you are spending $220,000 to $420,000 per year on manual data handling that a LIMS eliminates entirely.
The data integrity exposure is worse than the labor cost because it carries regulatory consequences. FDA's Data Integrity and Compliance With Drug CGMP guidance (2018) makes it explicit: data integrity failures are CGMP violations. When a QC analyst records a test result on paper, there is no audit trail showing the original instrument reading, no timestamp proving when the test was performed, no system-enforced control preventing the analyst from rewriting or selectively omitting a result. The same analyst can run a sample on an HPLC, see an out-of-spec result, discard the printout, re-run the sample, and record only the passing result — and the paper system has no mechanism to detect or prevent this. FDA investigators know this. It is why they pull instrument sequence logs during inspections and compare them against paper logbooks. Discrepancies between instrument audit trails and manual records are among the most damaging findings in a GMP inspection because they suggest data manipulation. This is not hypothetical. Ranbaxy, Able Labs, Wockhardt, and dozens of other manufacturers have faced consent decrees, import bans, and facility shutdowns directly tied to data integrity failures that originated in QC laboratories without adequate electronic controls.
The third cost category is operational: slow batch release, slow COA turnaround, and slow out-of-spec investigations. When QC results live in paper logbooks and spreadsheets, the QC manager has to manually collect results from multiple analysts, manually verify each result against the product specification, manually check that all required tests were performed, and manually approve the batch for release. This review cycle takes 2 to 5 business days at most manufacturers — days during which finished product sits in quarantine warehouse space, tying up working capital, delaying shipments, and straining customer relationships. If an out-of-spec result is found, the investigation process is entirely manual: pulling the original paper records, interviewing the analyst, checking instrument calibration logs that live in a separate binder, reviewing the preparation of standards and reagents from yet another logbook, and documenting the entire investigation in a Word document that gets routed for signatures via email. A single OOS investigation under this workflow consumes 40 to 80 analyst-hours over 2 to 4 weeks. Manufacturers running 10 to 20 OOS investigations per year are burning 400 to 1,600 hours — the equivalent of another full-time QC position — on investigation documentation alone.
Stability studies compound every one of these problems. ICH Q1A stability protocols require samples to be pulled at precise time intervals — 0, 3, 6, 9, 12, 18, 24, and 36 months for long-term studies, and 0, 1, 3, and 6 months for accelerated conditions. Each pull generates a full panel of tests. Each test result must be trended against previous timepoints. Each trend must be evaluated for statistically significant change. Managing this with spreadsheets means maintaining separate files for every product-lot-condition combination, manually updating them at each timepoint, and manually generating trend charts that a statistician or QC manager then reviews. When you are running 50 to 200 active stability protocols simultaneously — which is normal for a mid-size pharmaceutical or specialty chemical manufacturer — the spreadsheet approach is not just inefficient. It is structurally incapable of providing the real-time visibility into trending data that prevents a stability failure from becoming a market withdrawal.
150–225 hours per week of manual QC documentation labor across sample login, result entry, spec comparison, and COA generation ($220K–$420K/year in wasted technician time)
Zero audit trail on paper records — FDA investigators compare instrument sequence logs against logbooks and find discrepancies that suggest data manipulation
2–5 day batch release cycle because QC managers must manually collect, verify, and approve results from multiple analysts and logbooks
OOS investigations consuming 40–80 analyst-hours each over 2–4 weeks due to entirely manual root cause analysis and documentation
Stability studies managed in disconnected spreadsheets with no automated pull scheduling, no trend alerting, and no real-time protocol visibility
COAs generated by hand in Word or Excel — wrong spec limits, transposed results, and version control failures on every customer-facing document
Our engineers have built this exact solution for other businesses. Let's discuss your requirements.
A laboratory information management system is the software backbone of a QC lab. It manages the lifecycle of every sample from login to disposition: assigning unique identifiers, scheduling tests against product specifications, capturing results from instruments and analysts, comparing results to spec limits automatically, routing out-of-spec results into investigation workflows, generating Certificates of Analysis, and maintaining the complete chain-of-custody and audit trail that regulators require. When a LIMS is implemented correctly, a QC technician logs a sample in 30 seconds, the system assigns the correct test panel based on the material and specification, results flow directly from instruments into the LIMS via electronic integration, spec comparisons happen automatically at the moment of data capture, COAs generate with a single click, and the QC manager reviews and releases a batch in minutes instead of days. The audit trail is automatic, tamper-proof, and meets FDA 21 CFR Part 11 requirements without any additional effort from the analyst.
FreedomDev builds custom LIMS platforms for manufacturers who have outgrown spreadsheet-and-paper workflows but whose operations do not fit the rigid workflows of off-the-shelf LIMS products like LabWare, STARLIMS, or Thermo SampleManager. Off-the-shelf LIMS products are powerful, but they are designed to cover every possible laboratory type — clinical, environmental, research, forensic, QC — with a single configurable platform. The result is a system that can theoretically do anything but requires 12 to 24 months of configuration, $300,000 to $1,000,000+ in implementation costs, and an ongoing internal team of LIMS administrators to maintain the configuration. For a manufacturer with 10 to 50 QC lab staff running well-defined test methods on a focused product portfolio, that level of complexity is not just overkill — it is counterproductive. Configuration projects stall. User adoption suffers because the interface is cluttered with features nobody uses. Customizations required to match your actual lab workflows cost $15,000 to $50,000 each as vendor professional services engagements with 6-to-12-week lead times.
A custom LIMS built by FreedomDev matches your lab's actual sample types, test methods, specifications, instruments, approval hierarchies, and reporting requirements from day one. There is no configuration phase where a vendor consultant spends months mapping your workflows into their generic data model. We build the data model around your workflows. Your sample login screens show exactly the fields your technicians need — no more, no less. Your test entry screens match the way your analysts actually perform and record tests. Your specifications reflect your actual product hierarchy with the exact parameters, methods, units, and limits your lab uses. Your COA templates match the exact format your customers expect. Your OOS workflows follow your SOP step by step, with automatic routing, escalation rules, and deadline tracking built in.
Every sample gets a unique identifier at login — barcode or QR code printed on a label the moment the sample is registered. The system tracks the sample's physical location, assigned analyst, test status, and disposition from receipt through retention or disposal. Chain of custody is automatic: every time a sample changes hands, changes location, or changes status, the LIMS records who, when, and why. For manufacturers receiving 200 to 500 samples per week across raw materials, in-process, finished product, and stability pulls, sample login drops from 5 to 10 minutes of manual logbook entry to 30 seconds of barcode scanning. Sample search — finding a specific lot's test results from 18 months ago — drops from 30 minutes of binder-pulling to 3 seconds of database query.
Product specifications are defined once in the LIMS — material name, test parameters, analytical methods, units, lower spec limit, upper spec limit, target value, and reporting precision. When a test result is entered or imported from an instrument, the system compares it to the spec automatically and flags pass, fail, or marginal status instantly. No analyst judgment required for pass/fail determination. When specifications change — new customer requirements, regulatory updates, pharmacopeia method revisions — the LIMS maintains a full version history and applies the correct spec version to each sample based on the date of manufacture or date of receipt. This eliminates the most common COA error in paper-based labs: applying outdated spec limits to current production.
Direct bidirectional integration with laboratory instruments — HPLCs, GCs, ICP-OES, FTIR, Karl Fischer titrators, pH meters, moisture analyzers, particle size analyzers, and any instrument that outputs data electronically. Results flow from the instrument's data system directly into the LIMS sample record with no manual transcription. The integration captures the complete result set — not just the reportable value but also the run sequence, sample weight, dilution factor, system suitability parameters, and chromatographic data references. This eliminates transcription errors, creates an unbroken electronic chain from instrument to COA, and gives FDA investigators exactly what they want to see: proof that the reported result matches the instrument's raw output with no manual intervention point where data could be altered.
COAs generate automatically from the LIMS data — product name, lot number, manufacturing date, expiration date, test parameters, methods, specifications, results, and pass/fail status all pulled directly from the database. No retyping. No copy-paste from a logbook into a Word template. COA templates are configurable per customer: some customers want a one-page summary with reportable values and spec limits, others want detailed method references and uncertainty values, and regulated customers may require specific attestation language, electronic signatures, and laboratory accreditation references. A QC manager generates a COA in one click. Batch release that used to take 2 to 5 days of manual compilation now takes minutes. Every COA is stored, versioned, and retrievable by lot number, customer, date range, or product — permanently.
When a result fails specification, the LIMS immediately locks the sample record, prevents batch release, notifies the QC manager, and initiates a structured OOS investigation workflow that follows your SOP. Phase 1 (laboratory investigation): the system prompts the analyst to check instrument calibration, standard preparation, sample preparation, and calculation accuracy, and records their findings with timestamps and electronic signatures. If Phase 1 does not identify a root cause, Phase 2 (full-scale investigation) engages production, regulatory, and quality teams with assigned tasks, deadlines, and escalation rules. Every step is documented automatically. Investigation timelines are tracked in real time. Overdue tasks trigger escalation notifications. The completed investigation record — with all root cause analysis, corrective actions, and approval signatures — is a single auditable document that satisfies FDA, ISO, and customer audit requirements.
Full ICH Q1A/Q1B/Q1C stability protocol management — define storage conditions, timepoints, test panels, and acceptance criteria per protocol. The system automatically schedules sample pulls, generates pull lists for the stability chamber technician, tracks on-time versus late pulls, and alerts when a timepoint is approaching. As results are entered at each timepoint, the LIMS automatically trends data against previous timepoints and specification limits, generates trend charts, and flags statistically significant changes using configurable trend rules (e.g., Shewhart rules, regression analysis). When a stability result shows an adverse trend, the system alerts the stability program manager before the product goes out of specification — giving you months of lead time to investigate, adjust shelf life, or modify storage conditions instead of reacting to a failure after product is already in the market.
For pharmaceutical and food manufacturers operating classified cleanrooms or controlled environments, the LIMS manages environmental monitoring sample schedules — viable and non-viable particulate sampling, surface contact plates, personnel monitoring, temperature and humidity logging. Alert and action limits are defined per monitoring location and classification level. Excursions trigger automatic deviation workflows. Trend reports show environmental control performance over time by room, by shift, by season — the data FDA and SQF auditors ask for during facility inspections to evaluate your environmental control program's effectiveness.
Every LIMS we build includes Part 11 controls as foundational architecture, not bolted-on features. Database-level audit trails that record every create, modify, and delete action with operator identity, timestamp, original value, new value, and reason for change — immutable, not modifiable by database administrators. Electronic signatures with two-component authentication (username plus password or biometric), signature manifestation showing the signer's name, date, time, and meaning of the signature, and signer accountability policies enforced at the system level. Role-based access control that restricts each function to authorized personnel. Automatic session timeouts. Password policies. Authority checks on every data modification. These controls satisfy FDA investigators because they are built into the database layer, not the application layer — they cannot be bypassed.
We were running QC for 340 active product specifications on paper logbooks and Excel. Batch release took 3 to 4 days, and we were spending more time documenting results than analyzing samples. FreedomDev built a LIMS that matched our exact test workflows and instrument setup. Batch release is same-day now, our COAs generate in one click, and we passed our last FDA inspection with zero 483 observations related to data integrity.
We spend time in your lab — not just in conference rooms. We observe how samples are received, logged, distributed to analysts, tested, reviewed, and released. We document every sample type (raw material, in-process, finished product, stability, environmental), every test method, every product specification, every instrument, every approval workflow, every report format, and every regulatory requirement that governs your QC operations. We map your current pain points: where manual steps create bottlenecks, where data integrity gaps exist, where instrument data gets transcribed instead of captured electronically, and where batch release stalls waiting for manual compilation. Deliverable: a Lab Workflow Specification document that defines every sample flow, test workflow, specification structure, instrument integration requirement, report template, and regulatory control your LIMS must support — with a prioritized implementation roadmap and cost estimate per module.
Your lab's product hierarchy, specification structures, and test method relationships become the database schema. We define the data model for materials, products, lots, samples, tests, results, specifications, methods, instruments, analysts, and approvals — structured around how your lab actually organizes its work, not how a generic LIMS vendor thinks labs should work. Specification management gets particular attention: we build the version-controlled spec structure that handles your multi-tier product hierarchy (product family, product grade, customer-specific variants), your method-parameter relationships, your unit conversions, and your reporting precision rules. For manufacturers with 50 to 500+ active product specifications, this architecture determines whether the LIMS scales cleanly or becomes a maintenance burden.
We build the sample management core first: sample login, test assignment from specifications, result entry screens matched to your analysts' workflows, automatic spec comparison, and basic batch review and release. This core handles 80% of your daily QC workload and gives your team a working system to validate against their actual daily operations. Instrument integrations are built in parallel: we connect your highest-volume instruments first (typically HPLC, GC, and wet chemistry analyzers) using the instrument vendor's data output format — whether that is a CDS export (Empower, OpenLab, Chromeleon), a direct serial/TCP connection, XML, CSV, or a proprietary file format. Each integration is tested against your actual instrument output with your actual sample types to verify that every data field maps correctly.
Once the sample-to-result core is validated, we build the output and investigation layers. COA templates are designed with your QC manager and your customers' requirements in hand — every field placement, every attestation statement, every signature block matches exactly what your customers expect to receive. OOS workflows are built from your SOP: Phase 1 lab investigation steps, Phase 2 full-scale investigation routing, escalation rules, deadline tracking, and CAPA integration. The stability module adds protocol definition, pull scheduling, trend charting, and shelf-life analysis. Each module is delivered incrementally so your team can validate and provide feedback before the next module begins.
For FDA-regulated manufacturers, we execute IQ/OQ/PQ protocols with full traceability to user requirements. Installation Qualification verifies the system is installed per specification. Operational Qualification verifies every function works as designed — every calculation, every spec comparison, every workflow routing, every audit trail entry, every electronic signature, every report generation. Performance Qualification runs the system under your actual production conditions with your actual samples, analysts, and instruments for a defined validation period. Non-regulated manufacturers get the same rigor without the formal protocol documentation. In both cases, we run the LIMS in parallel with your existing paper or spreadsheet process for 2 to 4 weeks, comparing outputs batch-by-batch until accuracy is proven. Go-live is a cutover, not a guess.
| Metric | With FreedomDev | Without |
|---|---|---|
| Implementation Timeline | 3–6 months, matched to your workflows | LabWare/STARLIMS: 12–24 months configuration |
| Implementation Cost | $100K–$300K total (custom-built) | Off-the-shelf LIMS: $300K–$1M+ (licenses + configuration + validation) |
| Annual Maintenance | $2K–$5K/mo, no per-user licensing | $50K–$150K/yr in vendor maintenance + per-seat licenses |
| Workflow Customization | Built around your exact SOPs and test methods | Constrained to vendor's configurable framework; custom dev at $15K–$50K per change |
| Instrument Integration | Direct integration with your specific instruments | Vendor-supported instrument list only; unsupported instruments require custom connectors at added cost |
| User Adoption | Screens match how your analysts actually work — minimal training | Generic UI covering all lab types; 3–6 month adoption curve |
| Time to First Value | Core sample-to-COA live in 3–4 months | 12–18 months before first module is production-ready |
| Part 11 Compliance | Built into the database layer from day one | Available as a module — customer responsible for validation and configuration |
Schedule a direct technical consultation with our senior architects.
Make your software work for you. Let's build a sensible solution.